Search research articles
Contact Us
Filters
Showing results (81-90 of 103) with videos related to
Page
of 11
Sort By:
Pharmacopsychiatry
|
May 1, 1990
Pharmacological and behavioral profile of alpidem as an anxiolytic
B Zivkovic, E Morel, D Joly, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1988
In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype
J Benavides, B Peny, A Dubois, et al.
The Journal of Allergy and Clinical Immunology
|
June 1, 1992
Occupational asthma caused by a prepolymer but not the monomer of toluene diisocyanate (TDI)
O Vandenplas, A Cartier, J Lesage, et al.
AIHAJ : a Journal for the Science of Occupational and Environmental Health and Safety
|
October 24, 2001
Adjustment of permissible exposure values to unusual work schedules
J Brodeur, A Vyskocil, R Tardif, et al.
Psychopharmacology
|
October 20, 1999
New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes
G Griebel, G Perrault, V Letang, et al.
International Clinical Psychopharmacology
|
May 1, 1997
Amisulpride: from animal pharmacology to therapeutic action
B Scatton, Y Claustre, A Cudennec, et al.
The European Respiratory Journal
|
May 1, 1995
Occupational asthma due to formaldehyde resin dust with and without reaction to formaldehyde gas
C Lemière, A Desjardins, Y Cloutier, et al.
Neuroscience and Biobehavioral Reviews
|
January 1, 1994
Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes
D J Sanger, J Benavides, G Perrault, et al.
Psychopharmacology
|
April 15, 2005
SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit
J-P Terranova, C Chabot, M-C Barnouin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1986
Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects
H Depoortere, B Zivkovic, K G Lloyd, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 103) with videos related to
Sort By:
Page
of 11
Pharmacopsychiatry
|
May 1, 1990
Pharmacological and behavioral profile of alpidem as an anxiolytic
B Zivkovic, E Morel, D Joly, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1988
In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype
J Benavides, B Peny, A Dubois, et al.
The Journal of Allergy and Clinical Immunology
|
June 1, 1992
Occupational asthma caused by a prepolymer but not the monomer of toluene diisocyanate (TDI)
O Vandenplas, A Cartier, J Lesage, et al.
AIHAJ : a Journal for the Science of Occupational and Environmental Health and Safety
|
October 24, 2001
Adjustment of permissible exposure values to unusual work schedules
J Brodeur, A Vyskocil, R Tardif, et al.
Psychopharmacology
|
October 20, 1999
New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes
G Griebel, G Perrault, V Letang, et al.
International Clinical Psychopharmacology
|
May 1, 1997
Amisulpride: from animal pharmacology to therapeutic action
B Scatton, Y Claustre, A Cudennec, et al.
The European Respiratory Journal
|
May 1, 1995
Occupational asthma due to formaldehyde resin dust with and without reaction to formaldehyde gas
C Lemière, A Desjardins, Y Cloutier, et al.
Neuroscience and Biobehavioral Reviews
|
January 1, 1994
Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes
D J Sanger, J Benavides, G Perrault, et al.
Psychopharmacology
|
April 15, 2005
SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit
J-P Terranova, C Chabot, M-C Barnouin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1986
Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects
H Depoortere, B Zivkovic, K G Lloyd, et al.
Page
of 11